Ramesh B. Batchu

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Frits van Rhee, Susann Szmania, Fenghuang Zhan et al. · Blood · 2005 · 193 citations · Full text

Medicine, Hematology, Oncology +13

Dysfunctional homologous recombination mediates genomic instability and progression in myeloma

Masood A. Shammas, Robert J. Shmookler Reis, Hemanta Koley et al. · Blood · 2008 · 173 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +10

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications

Masood A. Shammas, Paola Neri, Hemanta Koley et al. · Blood · 2006 · 165 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo

Masood A. Shammas, Hemanta Koley, Robert C. Bertheau et al. · Leukemia · 2008 · 111 citations

Medicine, Molecular Biology, Oncology +13

Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential

Masood A. Shammas, Hemanta Koley, Ramesh B. Batchu et al. · Molecular Cancer · 2005 · 93 citations · Full text

Medicine, Cancer Biology, Oncology +17